- Report
- November 2023
- 124 Pages
Global
From €4318EUR$4,500USD£3,719GBP
- Report
- January 2023
- 124 Pages
Global
From €2159EUR$2,250USD£1,859GBP
- Report
- June 2022
- 215 Pages
United States
From €2590EUR$2,699USD£2,230GBP
- Report
- June 2021
- 195 Pages
United States
From €2399EUR$2,500USD£2,066GBP
- Report
- May 2021
- 70 Pages
United States
From €1439EUR$1,500USD£1,240GBP
- Report
- October 2019
- 310 Pages
Global
From €3310EUR$3,450USD£2,851GBP
- Report
- June 2019
- 220 Pages
Global
From €2101EUR$2,190USD£1,810GBP
- Report
- September 2021
- 104 Pages
Global
From €4318EUR$4,500USD£3,719GBP
- Report
- August 2022
- 120 Pages
Global
From €4318EUR$4,500USD£3,719GBP
Twinrix is a vaccine used to protect against both hepatitis A and hepatitis B. It is a combination of two vaccines, the hepatitis A vaccine and the hepatitis B vaccine, which are administered in a single dose. The vaccine is approved for use in adults and children over the age of one. It is recommended for people who are at risk of exposure to both hepatitis A and hepatitis B, such as healthcare workers, travelers, and those with chronic liver disease.
Twinrix is available in both a pediatric and adult formulation. The pediatric formulation is administered in three doses over a six-month period, while the adult formulation is administered in two doses over a one-month period. The vaccine is typically administered by injection, although it can also be administered intramuscularly.
Twinrix is manufactured by several companies, including GlaxoSmithKline, Sanofi Pasteur, Merck, and Pfizer. It is available in many countries around the world, including the United States, Canada, Australia, and the United Kingdom. Show Less Read more